《大行報告》瑞銀上調港交所(00388.HK)目標價至650元 評級「買入」
瑞銀發表報告指,其對港交所(00388.HK)投資論點的主要推動力包括市場擴展、多元化及流通加快,而三者表現超出該行的期望。其中港股年初至今日均交易量達2,400億元,意味市場流通率超過102%,雖然部分是由於北水流入,但該行預期市場擴展、生態系統改善及更佳的市場組合等基礎結構推動力,可繼續支持成交在活躍水平。
瑞銀上調港交所股份目標價,由460元升至650元,評級維持「買入」,並調升對港股今明兩年日均交易量預測18%至20%,最新預期今年日均交易可達1,930億元,明年進一步增至2,300億元,對比過去五年平均為960億元。
該行又預期,受惠於現金市場強勁、互聯互通貢獻增加及產品多元化,可助港交所今年至2023年的收入增長19%至35%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.